Literature DB >> 1763680

Cyclosporine A prevents neurological deterioration of patients with SAH--a preliminary report.

M Ryba1, M Pastuszko, K Iwanska, J Bidzinski, C Dziewiecki.   

Abstract

In the present study we found that the neurological outcome in patients anaesthetized for early clipping (up to 72 h after SAH) of a ruptured aneurysm and treated with cyclosporine A was significantly better than the neurological state of control patients without immuno-suppressive treatment. The results justify the presumption that auto-immune reactions are involved in the deterioration of the postoperative neurological state of patients with SAH after rupture of an intracranial aneurysm. Supplementing a standard surgical and pharmacological treatment with cyclosporine A seems to reduce the undesirable neurological consequences of the immunologically, induced vascular disturbance after SAH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763680     DOI: 10.1007/bf01402450

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

1.  Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood.

Authors:  P E Ball; H Munzer; H P Keller; E Abisch; J Rosenthaler
Journal:  Clin Chem       Date:  1988-02       Impact factor: 8.327

2.  Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale.

Authors: 
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

3.  Assessment of outcome after severe brain damage.

Authors:  B Jennett; M Bond
Journal:  Lancet       Date:  1975-03-01       Impact factor: 79.321

4.  Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery.

Authors:  J Ohman; O Heiskanen
Journal:  J Neurosurg       Date:  1988-11       Impact factor: 5.115

5.  Serum immunocomplexes in patients with subarachnoid hemorrhage.

Authors:  L Pellettieri; B Nilsson; C A Carlsson; U Nilsson
Journal:  Neurosurgery       Date:  1986-11       Impact factor: 4.654

6.  Timing and indication of surgery for ruptured intracranial aneurysms with regard to cerebral vasospasm.

Authors:  K Sano; I Saito
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

7.  Immune complexes and complement activation following rupture of intracranial saccular aneurysms.

Authors:  J R Ostergaard; B O Kristensen; S E Svehag; B Teisner; T Miletic
Journal:  J Neurosurg       Date:  1987-06       Impact factor: 5.115

8.  Is the vasospasm following subarachnoidal hemorrhage an immunoreactive disease?

Authors:  L Pellettieri; C A Carlson; L Lindholm
Journal:  Experientia       Date:  1981-11-15

9.  Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs.

Authors:  J W Peterson; S Nishizawa; J D Hackett; T Bun; A Teramura; N T Zervas
Journal:  Stroke       Date:  1990-01       Impact factor: 7.914

  9 in total
  17 in total

1.  HLA antigens and intracranial aneurysms.

Authors:  M Ryba; P Grieb; I Podobińska; K Iwańska; M Pastuszko; A Górski
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 2.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.

Authors:  Jasper H van Lieshout; Maxine Dibué-Adjei; Jan F Cornelius; Philipp J Slotty; Toni Schneider; Tanja Restin; Hieronymus D Boogaarts; Hans-Jakob Steiger; Athanasios K Petridis; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2017-02-18       Impact factor: 3.042

Review 3.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

4.  Endovascular treatment using low-power ultraviolet laser for delayed vasospasm in the rabbit carotid artery model.

Authors:  Kanji Nakai; Yuji Numaguchi; Thomas H Foster; Katsuji Shima; Makoto Kikuchi
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

Review 5.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

6.  Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats.

Authors:  Y Handa; T Kubota; M Kaneko; A Tsuchida; H Kobayashi; H Kawano; T Kubota
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Is vascular angiopathy following intracranial aneurysm rupture immunologically mediated?

Authors:  M Ryba; M Jarzabek-Chorzelska; T Chorzelski; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 8.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Morphometric and ultrastructural analysis of the effect of bromocriptine and cyclosporine on the vasospastic femoral artery of rats.

Authors:  Mehmet Tokmak; Kahan Başocak; Hüseyin Canaz; Gökhan Canaz; Celal İplikçioğlu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  A strategy for analyzing multiple parameters with application to aneurysmal SAH patients all of them clipped but treated with and without cyclosporine.

Authors:  M Ryba; M Pastuszko; C Dziewiecki; J Andrychowski; P Bojarski; M Barczewska
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.